Literature DB >> 19818311

Lifestyle modification as the primary treatment of NASH.

Brent A Neuschwander-Tetri1.   

Abstract

This article reviews the rationale and data behind recommending lifestyle changes to prevent and reverse NASH, focusing specifically on changes that lead to increased physical activity in sedentary patients, changes in dietary habits, and decreased calorie consumption to achieve gradual and sustained weight loss in those who are overweight or obese. In a culture that values avoiding even minimal exertion these are not easy changes to make. Ultimately, the success of care providers in helping patients to recognize and overcome these barriers depends on a patient's motivation, but clinicians can be more persuasive and able to bolster this motivation when armed with a conviction based on data that establish this to be the best course of action for patients with NASH.

Entities:  

Mesh:

Year:  2009        PMID: 19818311     DOI: 10.1016/j.cld.2009.07.006

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  18 in total

1.  Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

2.  Therapies for nonalcoholic steatohepatitis.

Authors:  Suzanne Mahady
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

3.  Task-based optimization of flip angle for fibrosis detection in T1-weighted MRI of liver.

Authors:  Jonathan F Brand; Lars R Furenlid; Maria I Altbach; Jean-Philippe Galons; Achyut Bhattacharyya; Puneet Sharma; Tulshi Bhattacharyya; Ali Bilgin; Diego R Martin
Journal:  J Med Imaging (Bellingham)       Date:  2016-07-21

Review 4.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

Review 5.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 6.  Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

Authors:  Juan P Arab; Roberto Candia; Rodrigo Zapata; Cristián Muñoz; Juan P Arancibia; Jaime Poniachik; Alejandro Soza; Francisco Fuster; Javier Brahm; Edgar Sanhueza; Jorge Contreras; M Carolina Cuellar; Marco Arrese; Arnoldo Riquelme
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

7.  Predictors of nonalcoholic steatohepatitis in obese children.

Authors:  Stacee Marie Lerret; Laura Garcia-Rodriguez; Joseph Skelton; Vincent Biank; Denise Kilway; Grzegorz Telega
Journal:  Gastroenterol Nurs       Date:  2011 Nov-Dec       Impact factor: 0.978

8.  Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy.

Authors:  Harald Kramer; Perry J Pickhardt; Mark A Kliewer; Diego Hernando; Guang-Hong Chen; James A Zagzebski; Scott B Reeder
Journal:  AJR Am J Roentgenol       Date:  2016-10-11       Impact factor: 3.959

9.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

Review 10.  Current concepts and management approaches in nonalcoholic fatty liver disease.

Authors:  Bashar M Attar; David H Van Thiel
Journal:  ScientificWorldJournal       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.